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Abstract
Background INTEGRA Dermal Regeneration Template
is a well-known and widely used acellular dermal matrix.
Although it helps to solve many challenging problems in
reconstructive surgery, the product cost may make it an
expensive alternative compared to other reconstruction
procedures. This retrospective study aims at comparing
INTEGRA-based treatment to flap surgery in terms of cost
and benefit.
Patients and Methods We considered only patients treated
for scalp defects with bone exposure in order to obtain two
groups as homogeneous as possible. We identified two
groups of patients: 17 patients treated with INTEGRA and
18 patients treated with flaps. All patients were admitted in
our institution between 2004 and 2010, and presented a
defect of the scalp following trauma or surgery for cancer,
causing a loss of the soft tissues of the scalp with bone
exposure without pericranium. To calculate the cost in
constant euros of each treatment, three parameters were
evaluated for each patient: cost of the surgical procedure
(number of doctors and nurses involved, surgery duration,
anesthesia, material used for surgery), hospitalization cost
(hospitalization duration, dressings, drugs, topical agents),
and outpatient cost (number of dressing changes, personnel
cost, dressings type, anti-infective agents). The statistical
test used in this study was the Wilcoxon Mann–Whitney
(a = 0.05).
Results No significant difference was characterized
between the two groups for gender, age, presence of dia-
betes, mean defect size, and number of surgical procedures.
All patients healed with good quality and durable closure.
The median total cost per patient was €11,121 (interquar-
tile range (IQR) 8327–15,571) for the INTEGRA group
and €7259 (IQR 1852–24,443) for the flap group
(p = 0.34). A subgroup of patients (six patients in the
INTEGRA group and five patients in the flap group)
showing defects larger than 100 cm2 were considered in a
second analysis. Median total cost was €11,825 (IQR
10,695–15,751) for the INTEGRA group and €23,244 (IQR
17,348–26,942) for the flap group.
Conclusion Both treatments led to a good healing of the
lesions with formation of soft and resistant tissue. No
significant difference was characterized between the two
groups for days of hospitalization and costs. In cases of
patients with defects larger than 100 cm2 for whom major
surgery is needed, the treatment with INTEGRA seemed to
be less expensive than the treatment with free flaps or
pedicle flaps.
Level of Evidence V This journal requires that authors
assign a level of evidence to each article. For a full
description of these Evidence-Based Medicine ratings,
please refer to the Table of Contents or the A5 online
Instructions to Authors.www.springer.com/00266.
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Introduction
INTEGRA Dermal Regeneration Template has been
commercialized since the 1980s. Its use was initially
described by Burke and colleagues in 1981 [1], and it is
now an important tool for the treatment of burns and scar
contractures [2, 3]. INTEGRA is also used for the recon-
struction of soft tissue loss following trauma, cancer
removal, and scar revision of all anatomical sites [4–6].
The specificity of INTEGRA is that it is perfectly inte-
grated where it is placed, regenerating a tridimensional
structure, known as neo-dermis, in which fibroblasts,
lymphocytes, macrophages, and neovascularization are
clearly detectable [3, 7–9]. This type of dermal regenera-
tion template offers multiple advantages: it allows imme-
diate closure of the wound, thus avoiding fluid loss and
restoring the functional barrier of the skin. It also prepares
the wound before the positioning of a split-thickness skin
graft. It is applicable in anatomical regions in which a graft
placement alone would not be preferred, such as on bone-
and tendon-exposed areas [4, 10], and improves the final
outcome and feature of the scar [11–13]. The positioning of
the matrix is relatively simple with a reduction of operating
time. It allows the reduction of hospitalization time and of
surgical sequelae for the patient [6, 14]. However, INTE-
GRA could also be susceptible to infection, needs a second
procedure for the coverage of the matrix with a skin graft,
and has a relatively high cost compared to autografts. The
latter is probably the main reason for its limited use in the
clinical practice: in fact, not all hospital administrations are
willing to authorize its purchase.
From the clinical literature perspective, only one cost
comparison study about INTEGRA use was identified. This
study compared the use of INTEGRA to split-thickness
skin grafts for the treatment of chronic wounds [15]. No
significant difference was characterized between the
groups in terms of charges, time to healing, narcotic use, or
antibiotic use, thus showing that the use of INTEGRA
could be an economically valid alternative treatment for
chronic wounds. In this context, it seems very interesting to
perform similar studies with larger samples and in other
indications.
This retrospective study was set up considering patients
affected by diseases for which INTEGRA is usually used in
a Department of Plastic Surgery such as tumor removal,
consequences of traumatic lesions, or burns. The patients
considered for this cost analysis study underwent surgery
for the reconstruction of scalp defects. Scalp reconstruction
was chosen because this anatomical area presents a good
vascular supply which is not influenced by alterations
caused by vascular disease or habits, and rehabilitation
does not require the patient to stay in bed. Total costs for
the management of these patients, from preparation of the
wound bed to complete wound healing, were calculated
and compared between patients who were treated with
INTEGRA and patients who had various forms of flap
surgery.
Patients and Methods
The study was a retrospective study. All consecutive
patients (38 patients) with neoplastic or traumatic lesions
were identified who underwent scalp reconstructive surgery
at our operative unit between 2004 and 2010. Among them,
18 patients had received INTEGRA Dermal Regeneration
Template bilayer followed by a secondary split-thickness
skin graft, and 20 patients had undergone flap surgery
(either with local flaps or microsurgical flaps or tissue
expansion) for the coverage of the tissue loss. All patients
presented with some area of denuded calvarian bone
without periosteum. The choice of the reconstruction
technique (INTEGRA or flap reconstruction) was related to
the general condition of the patients: i.e., some patients not
eligible for major surgical procedures or some patients with
bad tissue conditions (presence of scars or irradiated tis-
sues) were treated with INTEGRA. The dermal matrix was
placed on the wound during the first surgery, trimmed to
the size of the defect, and stapled. We milled the bone until
we had some bleeding before covering the wound bed with
INTEGRA.
No vacuum therapy was performed for the study patients
because the scalp is a very well vascularized structure.
Among the 20 patients who underwent flap reconstruction,
there were 14 pedicle flaps, 3 free flaps (latissimus dorsi),
and 1 skin expansion procedure (2 patients with too small
area treated were excluded). Patients of the INTEGRA
group were discharged quite rapidly after the first surgery
when allowed by their general condition. Following the
secondary split-thickness skin graft procedure, patients
were discharged after the first dressing change. After each
procedure, the first dressing change was performed on day
5. Subsequent dressing changes were performed as fre-
quently as needed. All dressing changes were performed
either in the hospital or in the author’s practice depending
on when the patient was discharged. Patients of the flap
group were discharged depending on the type of surgery
performed and their general condition. Outpatients were
discharged on the day of surgery and came back to the
author’s practice for the first dressing change 3–5 days
after the operation. Inpatients usually had their first
dressing change 2–3 days after surgery.
For each patient, personal data, date and duration of
hospitalization, and comorbidities were gathered.
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Concerning the lesions, if tumors were removed, the
dimensions of the lesions were recorded as well as the size
of tissue loss for both neoplastic and traumatic lesions. As
for the surgery, besides the type of surgery, the overall
operating time, the number of surgeons involved, the type
of anesthesia administered, and the materials used were
also recorded, as well as the medications and the supplies
used for the treatment during hospitalization and after
discharge of the patient, until complete wound healing.
To achieve an overall cost calculation in constant euros,
the management software used by the warehouse of the
hospital (Ascot Web, Insiel S.p.a., Trieste, Italy) provided
the unit costs of the materials and drugs. The hospital
management also provided all the data related to the hourly
hospital staff and operating room costs. The surgical pro-
cedures considered for the cost analysis were in all cases
removal of the lesion, plus one of the following procedures:
subsequent INTEGRA placement and coverage with skin
graft in a second stage, or repair with scalp flap, or delayed
repair with pedicle flap after skin expansion or not, or
repair with free flap.
Descriptive analysis was performed, and median,
interquartile range (IQR), mean, and standard deviation
(SD) were calculated. The cost and duration of hospital-
ization (inpatient and outpatient hospitalization) in each
group were compared by the Wilcoxon–Mann–Whitney
test. The alpha level was set to 0.05 for all tests. The sta-
tistical analysis was performed using SAS 9.2 (SAS Insti-
tute Inc., Cary, North Carolina, USA).
Results
Among the patients selected for inclusion in this study, one
patient treated with INTEGRA died of a stroke 2 weeks
after the surgery and was not kept for the analysis. To
increase the homogeneity of the group, it was also decided
to exclude two patients of the group treated with flaps
because the size of their lesions was too small (inferior to
3 cm2) to be compared with the other patients. The present
sample compiles data from 17 patients treated with
INTEGRA (8 men and 9 women) and 18 treated with flaps
(9 men and 9 women).
The median age of the patients included in the evalua-
tion at the time of their first surgery was 73 years (IQR
48–77) in the INTEGRA group and 71 years (IQR 56–84)
in the flap group. Diabetes was reported for three patients
(one patient in the INTEGRA group and two in the flap
group). Operated lesions were mainly neoplastic (76.5 %
of the cases in the INTEGRA group and 72.2 % in the flap
group). The median size of the defect was 56 cm2 (IQR
28–100) for the INTEGRA group and 20 cm2 (IQR 7–78)
for the flap group. The number of procedures performed for
each patient varies from 2 (76.5 % of the cases) to 3
(23.5 % of the cases) for the patients of the INTEGRA
group and from 1 (77.8 % of the cases) to 4 (5.6 % of the
cases) for the patients treated with flaps (Table 1).
A total of 56 inpatient admissions were recorded: 35 for
patients of the INTEGRA group and 21 for patients of the
flap group. Patients of the INTEGRA group were all
hospitalized twice: once for matrix implantation and once
for split-thickness skin grafting. The median value for the
total duration of inpatient hospitalization was 6.5 days
(IQR 5.0–9.5) for the INTEGRA group and 14.0 days
(IQR 10.0–28.0) for the flap group. Some outpatient
admissions were also reported. The median duration of the
outpatient follow-up was 10.5 days (IQR 10.0–11.0) for
the INTEGRA group and 6.5 days (IQR 4.0–8.0) for the
flap group (i.e., for one patient, a day hospital follow-up of
10 days corresponded to 10-day hospital admissions dur-
ing the treatment). Hospitalization durations are presented
in Table 2. The median surgery duration was 40.0 min
(IQR 10.0–55.0) for the INTEGRA group and 70.0 min
(IQR 10–170.0) for the flap group (Table 2). The long
surgery durations encountered in the flap group were
related to difficult tumor excision and subsequent flap
reconstruction.
Since the treatment with INTEGRA requires two sur-
gical procedures (first, matrix positioning and second,
coverage with split-thickness skin graft 1 month later), a
second analysis was performed pulling inpatient hospital-
izations as one. In that case, the median duration of hos-
pitalization reached 15.0 days for the INTEGRA group
(IQR 12.0–23.5) and 15.0 days (IQR 6.0–41.0) for the flap
group. No significant difference was evidenced between
the two groups (p value = 0.93).
The overall costs of hospitalization (in- and outpatient),
outpatient management, and surgery are presented in
Fig. 1. The median overall cost was 11,121.2€ (IQR
8326.9–15,751.1) for patients of the INTEGRA group and
7259.7€ (IQR 1852.1–24,443.4) for patients of the flap
group. No significant difference was characterized between
the two groups (p = 0.33).
When considering only patients who presented with a
lesion larger than 100 cm2 (six in the INTEGRA group and
five in the flap group), the median defect size was
120.0 cm2 (IQR 106.5–145.5) for patients of the INTE-
GRA group and 154.0 cm2 (IQR 113.0–154.0) for patients
of the flap group. The median overall cost was 11,824.99€
(IQR 10,694.93–15,751.12) for patients of the INTEGRA
group and 23,244.47€ (IQR 17,348.38–26,942.29) for
patients of the flap group (Table 3). For these patients who
usually need to be treated with microsurgery reconstructive
procedures because of the size of the defect, overall costs
seem to be twice as high for patients of the flap group
compared to patients of the INTEGRA group.
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Discussion
The reconstruction of scalp defects requires an immediate
coverage of the skull to preserve the anatomical features
and consistency of the surrounding tissues as much as
possible. These procedures can be particularly challenging
in the presence of large defects, in the case of cranial bone
exposure, and in the presence of scar tissues due to pre-
vious surgeries or after radiotherapy. There are different
publications showing the efficacy of INTEGRA in pro-
viding an adequate reconstruction alternative for chal-
lenging cases compared to traditional reconstructive
procedures [4, 16, 17].
The aim of the present retrospective study was to
compare the cost of two main surgical alternatives in scalp
reconstruction procedures where bone denuded of perios-
teum was exposed. Data about surgery, hospitalization, and
management were gathered in patients treated either with
INTEGRA or with flaps. No significant difference was
characterized between the two groups of patients
concerning their age, the reason, and the size of the scalp
defect.
From the analysis of the duration of hospitalization, it
was observed that admissions for the patients treated with
INTEGRA seemed shorter but, at the same time, patients
were admitted in the hospital at least twice because of the
2-step procedure. Overall, no significant difference was
characterized between the two groups for the duration of
hospitalization. The durations of hospitalization reported in
this study could be considered high compared to the liter-
ature [4, 18] where durations range from 2 to 7 days on
average. However, patients of the study were usually not
discharged because of their general condition and not
because of complications related to skin graft procedures.
Costs in constant euros were compared between the two
groups for hospital stay, surgery, and outpatient manage-
ment. Outpatient management cost was calculated consid-
ering material and human resources costs. While no
significant difference was found between the two groups
for hospital stay cost (p = 0.40), surgery cost was








Age Median (IQR) 73 (48–77) 71 (56–84) 71 (48–84) 0.9
Gender Male (%) 8 (47.1) 9 (50) 17 (48.6) –
Female (%) 9 (52.9) 9 (50) 18 (51.4)
Diabetes (%) 1 (5.9) 2 (11.1) –
Type of lesion Neoplastic (%) 13 (76.5) 13 (72.2) 26 (74.3) –
Traumatic (%) 3 (17.7) – 3 (8.6)
Degenerative (%) – 1 (5.6) 1 (2.9)
Iatrogenic (%) – 4 (22.2) 4 (11.4)
Infection (%) 1 (5.9) – 1 (2.9)
Lesion dimension in cm2 Median (IQR) 28 (10.0–78.5) 10.8 (3.0–35.0) – 0.22
Defect dimension in cm2 (after debridement) Median (IQR) 56 (28.0–100.0) 20 (7.0–78.5) – 0.22
Number of procedures (%) 1 0 14 (77.8) 14 (40.0) –
2 13 (76.5) 2 (11.1) 15 (42.9)
3 4 (23.5) 1 (5.6) 5 (14.3)
4 0 1 (5.6) 1 (2.9)





Mean (SD) Median (IQR) Mean (SD) Median (IQR)
Inpatient hospitalization duration (days) 9.4 (8.6) 6.5 (5.0–9.5) 21.8 (19.9) 14.0 (10.0–28.0)
Outpatient hospitalization duration (days) 10.5 (0.7) 10.5 (10.0–11.0) 6.0 (2.4) 6.5 (4.0–8.0)
Surgery duration (min) 48.2 (32.0) 40.0 (10.0–55.0) 139.2 (167.7) 70.0 (10.0–170.0)
The number of inpatient admissions considered was 35 for the INTEGRA group and 21 for the flap group. The number of outpatient admissions
considered was three for the INTEGRA group and four for the flap group
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significantly higher for the INTEGRA group (p = 0.01)
and outpatient cost significantly higher for the flap group
(p = 0.04). However, even with a higher median lesion
size in the INTEGRA group, no significant difference was
characterized between the two groups for the overall cost
(p = 0.34).
One limitation of this study is the relatively low number
of patients included in the analysis. Also, the size of the
lesions included in the analysis varied greatly from a few
cm2 to large defects of more than 100 cm2. As a conse-
quence, the overall cost calculated from patients’ data is
also relatively variable. In this context, it was very inter-
esting to analyze separately the more severe patients with
defects larger than 100 cm2. Despite not having a statistical
test that could be carried out because of the low number of
patients concerned, the use of INTEGRA seemed to reduce
the overall cost of the reconstruction compared to the use
of flaps. This preliminary result which should be confirmed
in a larger sample of patients somehow confirms a study
published in 2012 [19] which concluded that INTEGRA
was a reasonable tissue-engineered alternative to free tissue
transfer in medically compromised patients with complex
lower extremity wounds (denuded tendon and bone expo-
sure). However, in this paper, INTEGRA and Negative
Pressure Therapy (NPT) were associated with reduced
problems due to poor vascularization in the legs. In our
study, we did not use NPT because we treated wounds of



































































Fig. 1 Costs in euros presented per group for hospitalization (a), surgery (b), outpatients (c), and overall costs (d). Results are presented as
median, IQR, and minimal and maximal values. Wilcoxon–Mann–Whitney test were performed





Type of cost Mean (DS) Median (IQR) Mean (DS) Median (IQR)
Hospital stay 9572.5 (3030.8) 8205.0 (7658.0–13,128.0) 17,066.4 (9939.8) 19,692.0 (8205.0–21,333.0)
Surgery costs 3066.2 (583.4) 2880.1 (2693.9–3418.6) 6305.0 (4174.5) 5609.3 (3113.4–9143.4)
Outpatient costs 287.8 (305.8) 184.3 (124.1–222.3) 353.4 (108.4) 389.62 (231.6–439.1)
Total costs 12,926.5 (3210.9) 11,825.0 (10,694.9–15,751.1) 23,583.5 (12,675.0) 23,244.5 (17,348.4–26,942.3)
Outpatient and inpatient admissions were pooled for hospital stay cost calculations
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Today, in some cases, reconstruction with INTEGRA
can be performed in one step using INTEGRA Single
Layer, and this change will allow in the future a different
look at the costs for the INTEGRA procedure.
Another limitation of the results is related to the single
center design of the study. Also, cost calculation was based
on our hospital practices, and it is difficult to know how
reproducible it would be in another hospital or another
country. The retrospective design of the study could have
led to an information bias. Thus, the results presented here
have to be confirmed in larger scale prospective studies and
also in other countries.
Importantly, although this was not completely evaluated
in this study, the procedure with INTEGRA probably limits
discomfort for the patient because it allows for decreased
surgical time, with reduced donor site morbidity (only
split-thickness skin graft is required) and fast recovery rate.
This aspect is particularly important for elderly patients or
for patients with comorbidities who would have to face
serious risks if treated with major reconstructive surgical
procedures requiring microsurgery.
Each therapeutic choice during the treatment of a patient
has to be made considering patient-related factors like age,
comorbidities, and logistic factors (such as problems in
coming to the office for dressing changes). Since we
introduced the use of INTEGRA in our armamentarium for
scalp reconstruction, our algorithm for surgical treatment is
as follows (Fig. 2). We perform local flaps for defects
smaller than 3 9 3 cm and especially if hair is present. We
also use flaps to cover prosthetic material for example in
case of cranioplasty. In young people with non-malignant
pathologies and haired scalp, we prefer skin expansion
before lesion removal. In case of elderly people with
important comorbidities and large defects, we prefer using
INTEGRA and split-thickness skin graft, because it
decreases the duration of the surgical procedure and
anesthesia.
Conclusion
No significant difference was characterized for hospital-
ization duration and costs between the use of INTEGRA
Dermal Regeneration Template and the use of flaps for
reconstruction of scalp defects. Moreover, it seems that in
patients with larger defects requiring challenging surgical
procedures, the use of INTEGRA decreases the overall cost
of treatment by a factor of two. The common feeling that
INTEGRA may be an expensive treatment is not confirmed
by our cost analysis when considering the total cost of the
procedure, hospitalization, and outpatient costs. INTEGRA
appears to be a cost-effective therapeutic alternative for
reconstruction of scalp defects compared to flap surgery.
The results of this study need to be confirmed in a larger
multicenter study.
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